{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:11:42Z","timestamp":1780791102593,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11564-9","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:12:48Z","timestamp":1778321568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial intelligence-driven rational design and optimization of a potent terpenoid-derived PCSK9 inhibitor"],"prefix":"10.1007","author":[{"given":"Heng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZiYan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongHui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaHui","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LianXiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"10","key":"11564_CR1","doi-asserted-by":"publisher","first-page":"13209","DOI":"10.3390\/ijerph121013209","volume":"12","author":"X Huang","year":"2015","unstructured":"Huang X, Yang H, Wang HH, Qiu Y, Lai X, Zhou Z et al (2015) The association between physical activity, mental status, and social and family support with five major non-communicable chronic diseases among elderly people: a cross-sectional study of a rural population in Southern China. Int J Environ Res Public Health 12(10):13209\u201313223. https:\/\/doi.org\/10.3390\/ijerph121013209","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"11564_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa2415879","volume":"393","author":"C Magnussen","year":"2025","unstructured":"Magnussen C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, Aviles-Santa L, Bakker SJL et al (2025) Global effect of cardiovascular risk factors on lifetime estimates. N Engl J Med 393(2):125\u2013138. https:\/\/doi.org\/10.1056\/NEJMoa2415879","journal-title":"N Engl J Med"},{"key":"11564_CR3","unstructured":"Shahjehan RD, Sharma S, Bhutta BS. Coronary Artery Disease. StatPearls. Treasure Island (FL) with ineligible companies. Disclosure: Sanjeev Sharma declares no relevant financial relationships with ineligible companies. Disclosure: Beenish Bhutta declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.; 2025."},{"issue":"1","key":"11564_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02956-4","volume":"22","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Malik S, Criqui MH, Allison MA, Budoff MJ, Sandfort V et al (2022) Coronary calcium density in relation to coronary heart disease and cardiovascular disease in adults with diabetes or metabolic syndrome: the Multi-ethnic Study of Atherosclerosis (MESA). BMC Cardiovasc Disord 22(1):536. https:\/\/doi.org\/10.1186\/s12872-022-02956-4","journal-title":"BMC Cardiovasc Disord"},{"key":"11564_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108480","volume":"249","author":"S Hummelgaard","year":"2023","unstructured":"Hummelgaard S, Vilstrup JP, Gustafsen C, Glerup S, Weyer K (2023) Targeting PCSK9 to tackle cardiovascular disease. Pharmacol Ther 249:108480. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108480","journal-title":"Pharmacol Ther"},{"issue":"2","key":"11564_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ihj.2024.01.014","volume":"76","author":"S Hu","year":"2024","unstructured":"Hu S, Fan H, Zhang S, Chen C, You Y, Wang C et al (2024) Association of LDL-C\/HDL-C ratio with coronary heart disease: a meta-analysis. Indian Heart J 76(2):79\u201385. https:\/\/doi.org\/10.1016\/j.ihj.2024.01.014","journal-title":"Indian Heart J"},{"issue":"5","key":"11564_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/mol.0000000000000945","volume":"35","author":"J Golledge","year":"2024","unstructured":"Golledge J, Lu HS, Shah S (2024) Proprotein convertase subtilisin\/kexin type 9 as a drug target for abdominal aortic aneurysm. Curr Opin Lipidol 35(5):241\u2013247. https:\/\/doi.org\/10.1097\/mol.0000000000000945","journal-title":"Curr Opin Lipidol"},{"issue":"21","key":"11564_CR8","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/circulationaha.124.072336","volume":"151","author":"Y Guan","year":"2025","unstructured":"Guan Y, Liu X, Yang Z, Zhu X, Liu M, Du M et al (2025) PCSK9 promotes LDLR degradation by preventing SNX17-mediated LDLR recycling. Circulation 151(21):1512\u20131526. https:\/\/doi.org\/10.1161\/circulationaha.124.072336","journal-title":"Circulation"},{"issue":"3","key":"11564_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/endrev\/bnab035","volume":"43","author":"NG Seidah","year":"2022","unstructured":"Seidah NG, Prat A (2022) The multifaceted biology of PCSK9. Endocr Rev 43(3):558\u2013582. https:\/\/doi.org\/10.1210\/endrev\/bnab035","journal-title":"Endocr Rev"},{"key":"11564_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020286","author":"NB Charbe","year":"2024","unstructured":"Charbe NB, Zacconi FC, Kowthavarapu VK, Gupta C, Palakurthi SS, Satheeshkumar R et al (2024) Targeting allosteric site of PCSK9 enzyme for the identification of small molecule inhibitors: an in silico drug repurposing study. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12020286","journal-title":"Biomedicines"},{"key":"11564_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051550","author":"WR Martin","year":"2020","unstructured":"Martin WR, Lightstone FC, Cheng F (2020) In silico insights into protein-protein interaction disruptive mutations in the PCSK9-LDLR complex. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21051550","journal-title":"Int J Mol Sci"},{"issue":"42","key":"11564_CR12","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.2174\/0109298673262124231102042914","volume":"31","author":"MT Macvanin","year":"2024","unstructured":"Macvanin MT, Gluvic ZM, Klisic AN, Manojlovic MS, Suri JS, Rizzo M et al (2024) The link between miRNAs and PCKS9 in atherosclerosis. Curr Med Chem 31(42):6926\u20136956. https:\/\/doi.org\/10.2174\/0109298673262124231102042914","journal-title":"Curr Med Chem"},{"issue":"9965","key":"11564_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","volume":"385","author":"FJ Raal","year":"2015","unstructured":"Raal FJ, Stein EA, Dufour R, Turner T, Civeira F, Burgess L et al (2015) PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. The Lancet 385(9965):331\u2013340. https:\/\/doi.org\/10.1016\/S0140-6736(14)61399-4","journal-title":"The Lancet"},{"issue":"10","key":"11564_CR14","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1038\/s41401-024-01305-9","volume":"45","author":"WZ Wang","year":"2024","unstructured":"Wang WZ, Liu C, Luo JQ, Lei LJ, Chen MH, Zhang YY et al (2024) A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis. Acta Pharmacol Sin 45(10):2119\u20132133. https:\/\/doi.org\/10.1038\/s41401-024-01305-9","journal-title":"Acta Pharmacol Sin"},{"key":"11564_CR15","doi-asserted-by":"publisher","unstructured":"Fowler A, Van Rompay KKA, Sampson M, Leo J, Watanabe JK, Usachenko JL, et al. A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human Primates. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.05.15.540560.","DOI":"10.1101\/2023.05.15.540560"},{"issue":"Pt A","key":"11564_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109318","volume":"113","author":"RLG Al-Awsi","year":"2022","unstructured":"Al-Awsi RLG, Lafta HM, Kzar HH, Samieva G, Alsaikhan F, Ahmad I et al (2022) PCSK9 pathway-noncoding RNAs crosstalk: emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis. Int Immunopharmacol 113(Pt A):109318. https:\/\/doi.org\/10.1016\/j.intimp.2022.109318","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"11564_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28240-9","volume":"13","author":"PF Lebeau","year":"2022","unstructured":"Lebeau PF, Byun JH, Platko K, Saliba P, Sguazzin M, MacDonald ME et al (2022) Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance. Nat Commun 13(1):770. https:\/\/doi.org\/10.1038\/s41467-022-28240-9","journal-title":"Nat Commun"},{"key":"11564_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47060433","author":"M Bahrudin","year":"2025","unstructured":"Bahrudin M, Al Fauzi A, Sugianto P (2025) Effectiveness of red watermelon in preventing atherosclerosis through the role of lipids, PCSK9, LOX-1, CD36, and ABCA1 in Wistar rats. Curr Issues Mol Biol. https:\/\/doi.org\/10.3390\/cimb47060433","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"11564_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46336-2","volume":"15","author":"D Shin","year":"2024","unstructured":"Shin D, Kim S, Lee H, Lee HC, Lee J, Park HW et al (2024) PCSK9 stimulates Syk, PKC\u03b4, and NF-\u03baB, leading to atherosclerosis progression independently of LDL receptor. Nat Commun 15(1):2789. https:\/\/doi.org\/10.1038\/s41467-024-46336-2","journal-title":"Nat Commun"},{"key":"11564_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5830491","volume":"2024","author":"B Bagheri","year":"2024","unstructured":"Bagheri B, Khatibiyan Feyzabadi Z, Nouri A, Azadfallah A, Mahdizade Ari M, Hemmati M et al (2024) Atherosclerosis and Toll-Like Receptor4 (TLR4), Lectin-Like Oxidized Low-Density Lipoprotein-1 (LOX-1), and Proprotein Convertase Subtilisin\/Kexin Type9 (PCSK9). Mediators Inflamm 2024:5830491. https:\/\/doi.org\/10.1155\/2024\/5830491","journal-title":"Mediators Inflamm"},{"key":"11564_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117608","volume":"397","author":"TKT Smith","year":"2024","unstructured":"Smith TKT, Ghorbani P, LeBlond ND, Nunes JRC, O\u2019Dwyer C, Ambursley N et al (2024) AMPK-mediated regulation of endogenous cholesterol synthesis does not affect atherosclerosis in a murine Pcsk9-AAV model. Atherosclerosis 397:117608. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117608","journal-title":"Atherosclerosis"},{"key":"11564_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2024.102186","volume":"38","author":"VK Bhardwaj","year":"2024","unstructured":"Bhardwaj VK, Purohit R (2024) Potential acridinedione derivatives for the development of a heterobifunctional PROTAC for targeted degradation of PCSK9 protein. Appl Mater Today 38:102186. https:\/\/doi.org\/10.1016\/j.apmt.2024.102186","journal-title":"Appl Mater Today"},{"issue":"1","key":"11564_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00218-7","volume":"5","author":"Z Ma","year":"2024","unstructured":"Ma Z, Zhong J, Tu W, Li S, Chen J (2024) The functions of apolipoproteins and lipoproteins in health and disease. Mol Biomed 5(1):53. https:\/\/doi.org\/10.1186\/s43556-024-00218-7","journal-title":"Mol Biomed"},{"issue":"16","key":"11564_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1055\/a-1932-6448","volume":"148","author":"D Sinning","year":"2023","unstructured":"Sinning D, Landmesser U (2023) [Hypercholesterolemia and cardiovascular risk]. Dtsch Med Wochenschr 148(16):1025\u20131032. https:\/\/doi.org\/10.1055\/a-1932-6448","journal-title":"Dtsch Med Wochenschr"},{"key":"11564_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/20406223251334439","volume":"16","author":"J Tang","year":"2025","unstructured":"Tang J, Song T, Kuang M, Liu H (2025) Opportunities and challenges of lifestyle intervention-based digital therapeutics in LDL-C management: a scoping review. Ther Adv Chronic Dis 16:20406223251334439. https:\/\/doi.org\/10.1177\/20406223251334439","journal-title":"Ther Adv Chronic Dis"},{"issue":"2","key":"11564_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1517\/13543776.2011.547478","volume":"21","author":"JA Pfefferkorn","year":"2011","unstructured":"Pfefferkorn JA (2011) Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review. Expert Opin Ther Pat 21(2):187\u2013203. https:\/\/doi.org\/10.1517\/13543776.2011.547478","journal-title":"Expert Opin Ther Pat"},{"issue":"8","key":"11564_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/00325481.2017.1376570","volume":"129","author":"C W\u00f3jcik","year":"2017","unstructured":"W\u00f3jcik C (2017) Incorporation of PCSK9 inhibitors into prevention of atherosclerotic cardiovascular disease. Postgrad Med 129(8):801\u2013810. https:\/\/doi.org\/10.1080\/00325481.2017.1376570","journal-title":"Postgrad Med"},{"issue":"4","key":"11564_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ehjcvp\/pvad009","volume":"9","author":"VA Myasoedova","year":"2023","unstructured":"Myasoedova VA, Rimbert A, Camera M, Le May C, Capoulade R, Cariou B et al (2023) LDL lowering effect of PCSK9 inhibition is reduced in women. Eur Heart J Cardiovasc Pharmacother 9(4):337\u2013342. https:\/\/doi.org\/10.1093\/ehjcvp\/pvad009","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"11564_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/10742484221100107","volume":"27","author":"C Coppinger","year":"2022","unstructured":"Coppinger C, Movahed MR, Azemawah V, Peyton L, Gregory J, Hashemzadeh M (2022) A comprehensive review of PCSK9 inhibitors. J Cardiovasc Pharmacol Ther 27:10742484221100107. https:\/\/doi.org\/10.1177\/10742484221100107","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"11564_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/genes14030669","author":"SE van den Bosch","year":"2023","unstructured":"van den Bosch SE, Corpeleijn WE, Hutten BA, Wiegman A (2023) How genetic variants in children with familial hypercholesterolemia not only guide detection, but also treatment. Genes. https:\/\/doi.org\/10.3390\/genes14030669","journal-title":"Genes"},{"issue":"2","key":"11564_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jacl.2019.01.005","volume":"13","author":"T Knickelbine","year":"2019","unstructured":"Knickelbine T, Jia L, White SK, Garberich RF, Oberembt SJ, Wills S et al (2019) A systematic approach for successful PCSK9 inhibitor prescribing in clinical practice. J Clin Lipidol 13(2):265\u2013271. https:\/\/doi.org\/10.1016\/j.jacl.2019.01.005","journal-title":"J Clin Lipidol"},{"key":"11564_CR32","doi-asserted-by":"publisher","DOI":"10.1039\/d5md00361j","author":"A Gupta","year":"2025","unstructured":"Gupta A, Thind AS, Purohit R (2025) EGFR(AP): a predictive machine learning model for assessing small molecule activity against the epidermal growth factor receptor. RSC Med Chem. https:\/\/doi.org\/10.1039\/d5md00361j","journal-title":"RSC Med Chem"},{"issue":"10","key":"11564_CR33","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1021\/acs.analchem.4c05138","volume":"97","author":"Y Ma","year":"2025","unstructured":"Ma Y, Shih CH, Cheng J, Chen HC, Wang LJ, Tan Y et al (2025) High-throughput empirical and virtual screening to discover novel inhibitors of polyploid giant cancer cells in breast cancer. Anal Chem 97(10):5498\u20135506. https:\/\/doi.org\/10.1021\/acs.analchem.4c05138","journal-title":"Anal Chem"},{"issue":"14","key":"11564_CR34","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1021\/acs.jpcb.4c07651","volume":"129","author":"KK Bhanja","year":"2025","unstructured":"Bhanja KK, Patra N (2025) Identification of novel fourth-generation allosteric inhibitors targeting inactive state of EGFR T790M\/L858R\/C797S and T790M\/L858R mutations: a combined machine learning and molecular dynamics approach. J Phys Chem B 129(14):3610\u20133629. https:\/\/doi.org\/10.1021\/acs.jpcb.4c07651","journal-title":"J Phys Chem B"},{"issue":"4","key":"11564_CR35","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1021\/acs.jcim.3c01964","volume":"64","author":"M Wang","year":"2024","unstructured":"Wang M, Wu Z, Wang J, Weng G, Kang Y, Pan P et al (2024) Genetic algorithm-based receptor ligand: a genetic algorithm-guided generative model to boost the novelty and drug-likeness of molecules in a sampling chemical space. J Chem Inf Model 64(4):1213\u20131228. https:\/\/doi.org\/10.1021\/acs.jcim.3c01964","journal-title":"J Chem Inf Model"},{"issue":"1","key":"11564_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2024.2301756","volume":"39","author":"Y Liao","year":"2024","unstructured":"Liao Y, Cao P, Luo L (2024) Development of novel ALOX15 inhibitors combining dual machine learning filtering and fragment substitution optimisation approaches, molecular docking and dynamic simulation methods. J Enzyme Inhib Med Chem 39(1):2301756. https:\/\/doi.org\/10.1080\/14756366.2024.2301756","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"11564_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/157340609787582873","volume":"5","author":"S Balaji","year":"2009","unstructured":"Balaji S, Chempakam B (2009) Pharmacokinetics prediction and drugability assessment of diphenylheptanoids from turmeric (Curcuma longa L). Med Chem 5(2):130\u2013138. https:\/\/doi.org\/10.2174\/157340609787582873","journal-title":"Med Chem"},{"key":"11564_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1619517","volume":"16","author":"W Wang","year":"2025","unstructured":"Wang W, Liu H, Wen Y, Zhang Y, Ma X (2025) An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib. Front Pharmacol 16:1619517. https:\/\/doi.org\/10.3389\/fphar.2025.1619517","journal-title":"Front Pharmacol"},{"key":"11564_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151614","volume":"758","author":"B Sharma","year":"2025","unstructured":"Sharma B, Purohit R (2025) Enhanced sampling simulations to explore Himalayan phytochemicals as potential phosphodiesterase-1 inhibitor for neurological disorders. Biochem Biophys Res Commun 758:151614. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151614","journal-title":"Biochem Biophys Res Commun"},{"key":"11564_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151575","volume":"756","author":"R Singh","year":"2025","unstructured":"Singh R, Purohit R (2025) Determining the effect of natural compounds on mutations of pyrazinamidase in multidrug-resistant tuberculosis: illuminating the dark tunnel. Biochem Biophys Res Commun 756:151575. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151575","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"11564_CR41","doi-asserted-by":"publisher","first-page":"9566","DOI":"10.1021\/acs.jcim.5c00892","volume":"65","author":"C Tian","year":"2025","unstructured":"Tian C, Hao Y, Fu H, Shao X, Cai W (2025) From AI-driven sequence generation to molecular simulation: a comprehensive framework for antimicrobial peptide discovery. J Chem Inf Model 65(18):9566\u20139575. https:\/\/doi.org\/10.1021\/acs.jcim.5c00892","journal-title":"J Chem Inf Model"},{"issue":"1","key":"11564_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/1735-5362.394818","volume":"19","author":"M Abbasi","year":"2024","unstructured":"Abbasi M, Mansourian M, Oskouie AA, Taheri S, Mahnam K (2024) In-silico study MM\/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease. Res Pharm Sci 19(1):29\u201341. https:\/\/doi.org\/10.4103\/1735-5362.394818","journal-title":"Res Pharm Sci"},{"issue":"2","key":"11564_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.481","volume":"5","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yu W, Li Y, Wang A, Cao H, Fu Y (2024) Drug development advances in human genetics-based targets. MedComm 5(2):e481. https:\/\/doi.org\/10.1002\/mco2.481","journal-title":"MedComm"},{"issue":"14","key":"11564_CR44","doi-asserted-by":"publisher","first-page":"13026","DOI":"10.1021\/acsomega.3c00225","volume":"8","author":"S Ahamad","year":"2023","unstructured":"Ahamad S, Hema K, Gupta D (2023) Identification of novel Tau-Tubulin Kinase 2 inhibitors using computational approaches. ACS Omega 8(14):13026\u201313037. https:\/\/doi.org\/10.1021\/acsomega.3c00225","journal-title":"ACS Omega"},{"key":"11564_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ph17070952","author":"S Ahamad","year":"2024","unstructured":"Ahamad S, Junaid IT, Gupta D (2024) Computational design of novel Tau-Tubulin Kinase 1 inhibitors for neurodegenerative diseases. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph17070952","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"11564_CR46","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1039\/d0ra07659g","volume":"11","author":"S Ahamad","year":"2021","unstructured":"Ahamad S, Kanipakam H, Kumar V, Gupta D (2021) A molecular journey to check the conformational dynamics of tau tubulin kinase 2 mutations associated with Alzheimer\u2019s disease. RSC Adv 11(3):1320\u20131331. https:\/\/doi.org\/10.1039\/d0ra07659g","journal-title":"RSC Adv"},{"issue":"11","key":"11564_CR47","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/jcb.30112","volume":"122","author":"S Ahamad","year":"2021","unstructured":"Ahamad S, Hema K, Kumar V, Gupta D (2021) The structural, functional, and dynamic effect of Tau tubulin kinase1 upon a mutation: a neuro-degenerative hotspot. J Cell Biochem 122(11):1653\u20131664. https:\/\/doi.org\/10.1002\/jcb.30112","journal-title":"J Cell Biochem"},{"issue":"5","key":"11564_CR48","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1080\/07391102.2021.2024449","volume":"41","author":"S Yadav","year":"2023","unstructured":"Yadav S, Ahamad S, Gupta D, Mathur P (2023) Lead optimization, pharmacophore development and scaffold design of protein kinase CK2 inhibitors as potential COVID-19 therapeutics. J Biomol Struct Dyn 41(5):1811\u20131827. https:\/\/doi.org\/10.1080\/07391102.2021.2024449","journal-title":"J Biomol Struct Dyn"},{"key":"11564_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2023.1138057","volume":"11","author":"AKD Alsukaibi","year":"2023","unstructured":"Alsukaibi AKD, Alenezi KM, Haque A, Ahmad I, Saeed M, Verma M et al (2023) Chemical, biological and in silico assessment of date (P. dactylifera L.) fruits grown in Ha\u2019il region. Front Chem 11:1138057. https:\/\/doi.org\/10.3389\/fchem.2023.1138057","journal-title":"Front Chem"},{"issue":"3","key":"11564_CR50","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/med.21764","volume":"41","author":"S Vatansever","year":"2021","unstructured":"Vatansever S, Schlessinger A, Wacker D, Kaniskan H, Jin J, Zhou MM et al (2021) Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: state-of-the-arts and future directions. Med Res Rev 41(3):1427\u20131473. https:\/\/doi.org\/10.1002\/med.21764","journal-title":"Med Res Rev"},{"issue":"1","key":"11564_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10822-022-00490-1","volume":"37","author":"J Ren","year":"2023","unstructured":"Ren J, Vaid TM, Lee H, Ojeda I, Johnson ME (2023) Evaluation of interactions between the hepatitis C virus NS3\/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations. J Comput Aided Mol Des 37(1):53\u201365. https:\/\/doi.org\/10.1007\/s10822-022-00490-1","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"11564_CR52","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/1747493018778713","volume":"13","author":"D Sacks","year":"2018","unstructured":"Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D et al (2018) Multisociety Consensus Quality Improvement Revised Consensus Statement for endovascular therapy of acute ischemic stroke. Int J Stroke 13(6):612\u2013632. https:\/\/doi.org\/10.1177\/1747493018778713","journal-title":"Int J Stroke"},{"issue":"3","key":"11564_CR53","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s11030-021-10262-y","volume":"25","author":"Q Cai","year":"2021","unstructured":"Cai Q, Yuan R, He J, Li M, Guo Y (2021) Predicting HIV drug resistance using weighted machine learning method at target protein sequence-level. Mol Divers 25(3):1541\u20131551. https:\/\/doi.org\/10.1007\/s11030-021-10262-y","journal-title":"Mol Divers"},{"issue":"8","key":"11564_CR54","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1021\/acs.jcim.3c01979","volume":"64","author":"K Yang","year":"2024","unstructured":"Yang K, Xie Z, Li Z, Qian X, Sun N, He T et al (2024) MolProphet: a one-stop, general purpose, and AI-based platform for the early stages of drug discovery. J Chem Inf Model 64(8):2941\u20132947. https:\/\/doi.org\/10.1021\/acs.jcim.3c01979","journal-title":"J Chem Inf Model"},{"key":"11564_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30132685","author":"B Jovi\u0107","year":"2025","unstructured":"Jovi\u0107 B, Negru N, Dimi\u0107 D, Kordi\u0107 B (2025) Vibrational spectroscopic and quantum-chemical study of indole-ketone hydrogen-bonded complexes. Molecules. https:\/\/doi.org\/10.3390\/molecules30132685","journal-title":"Molecules"},{"issue":"7","key":"11564_CR56","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jcc.21707","volume":"32","author":"CW Yap","year":"2011","unstructured":"Yap CW (2011) PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem 32(7):1466\u20131474. https:\/\/doi.org\/10.1002\/jcc.21707","journal-title":"J Comput Chem"},{"issue":"2268","key":"11564_CR57","doi-asserted-by":"publisher","DOI":"10.1098\/rsta.2023.0004","volume":"382","author":"A Brandenburger","year":"2024","unstructured":"Brandenburger A, Contreras-Tejada P, La Mura P, Scarpa G, Steverson K (2024) Agreement and disagreement in a non-classical world. Philos Trans R Soc A Math Phys Eng Sci 382(2268):20230004. https:\/\/doi.org\/10.1098\/rsta.2023.0004","journal-title":"Philos Trans R Soc A Math Phys Eng Sci"},{"key":"11564_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ma18133054","author":"X Cai","year":"2025","unstructured":"Cai X, Wang Y, Zhao Y, Chen L, Wang P, Wang Z et al (2025) Dynamic strength prediction of brittle engineering materials via stacked multi-model ensemble learning and interpretability-driven feature analysis. Materials (Basel). https:\/\/doi.org\/10.3390\/ma18133054","journal-title":"Materials (Basel)"},{"issue":"3","key":"11564_CR59","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1016\/s2666-5247(23)00363-4","volume":"5","author":"M Carney","year":"2024","unstructured":"Carney M, Pelaia TM, Chew T, Teoh S, Phu A, Kim K et al (2024) Host transcriptomics and machine learning for secondary bacterial infections in patients with COVID-19: a prospective, observational cohort study. Lancet Microbe 5(3):e272\u2013e281. https:\/\/doi.org\/10.1016\/s2666-5247(23)00363-4","journal-title":"Lancet Microbe"},{"key":"11564_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1-2","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"issue":"8","key":"11564_CR61","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO et al (2010) Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78(8):1950\u20131958. https:\/\/doi.org\/10.1002\/prot.22711","journal-title":"Proteins"},{"issue":"6","key":"11564_CR62","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO (2018) Molecular dynamics simulation for all. Neuron 99(6):1129\u20131143. https:\/\/doi.org\/10.1016\/j.neuron.2018.08.011","journal-title":"Neuron"},{"issue":"10","key":"11564_CR63","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1021\/acs.jcim.1c00521","volume":"61","author":"H Sun","year":"2021","unstructured":"Sun H, Wang J, Liu S, Zhou X, Dai L, Chen C et al (2021) Discovery of novel small molecule inhibitors disrupting the PCSK9-LDLR interaction. J Chem Inf Model 61(10):5269\u20135279. https:\/\/doi.org\/10.1021\/acs.jcim.1c00521","journal-title":"J Chem Inf Model"},{"issue":"2","key":"11564_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/circulationaha.122.063372","volume":"148","author":"DG Johns","year":"2023","unstructured":"Johns DG, Campeau LC, Banka P, Bautmans A, Bueters T, Bianchi E et al (2023) Orally bioavailable macrocyclic peptide that inhibits binding of PCSK9 to the low density lipoprotein receptor. Circulation 148(2):144\u2013158. https:\/\/doi.org\/10.1161\/circulationaha.122.063372","journal-title":"Circulation"},{"key":"11564_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2023.129394","volume":"92","author":"GE Aspnes","year":"2023","unstructured":"Aspnes GE, Coffey SB, Darout E, Dechert-Schmitt AM, Dullea RG, Kamlet AS et al (2023) Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups. Bioorg Med Chem Lett 92:129394. https:\/\/doi.org\/10.1016\/j.bmcl.2023.129394","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11564-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11564-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11564-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:13:03Z","timestamp":1778321583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11564-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":65,"alternative-id":["11564"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11564-9","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}